Novo Warns Users Of Stolen Shipment Of Insulin

Law360, New York (June 15, 2009, 12:00 AM EDT) -- Novo Nordisk Inc. has warned consumers that a stolen shipment of its long-acting insulin drug Levemir is now being sold in the United States and could pose a danger to users.

The shipment, which contained 129,000 vials of the prescription drug, resurfaced last week at a medical center in Houston, the company said on Saturday.

The U.S. Food and Drug Administration said it had already received one report of an adverse reaction related to the stolen shipment from a patient who suffered “poor control of glucose...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.